Candriam S.C.A. Buys New Shares in Docusign Inc. $DOCU

Key Points

• Candriam S.C.A. acquired 50,936 shares of Docusign Inc., valued at approximately $4.15 million, during the first quarter, as reported in their Form 13F filing.
• Docusign's latest quarterly earnings revealed an EPS of $0.90, surpassing expectations, along with a revenue of $763.65 million, a 7.6% increase from the same quarter last year.
• The company announced a stock buyback plan, allowing for up to $1.00 billion to be used to repurchase shares, which is an indication that the board believes the stock is undervalued.

Candriam S.C.A. acquired a new position in Docusign Inc. (NASDAQ:DOCU - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 50,936 shares of the company's stock, valued at approximately $4,146,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Hemington Wealth Management grew its position in shares of Docusign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock worth $28,000 after buying an additional 264 shares in the last quarter. Golden State Wealth Management LLC lifted its stake in Docusign by 519.4% in the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after acquiring an additional 322 shares during the period. Summit Securities Group LLC bought a new position in Docusign during the 1st quarter worth about $34,000. Wood Tarver Financial Group LLC purchased a new position in Docusign during the 4th quarter valued at about $37,000. Finally, MassMutual Private Wealth & Trust FSB increased its position in Docusign by 153.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company's stock valued at $37,000 after purchasing an additional 274 shares during the period. 77.64% of the stock is owned by institutional investors.

Docusign Trading Up 0.9%

NASDAQ:DOCU traded up $0.66 during trading hours on Thursday, hitting $75.34. The company had a trading volume of 373,893 shares, compared to its average volume of 2,564,539. The company has a market cap of $15.22 billion, a P/E ratio of 14.25, a P/E/G ratio of 27.06 and a beta of 1.01. The company has a 50-day moving average of $75.37 and a 200 day moving average of $79.97. Docusign Inc. has a 1 year low of $54.31 and a 1 year high of $107.86.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, topping analysts' consensus estimates of $0.81 by $0.09. The firm had revenue of $763.65 million during the quarter, compared to analysts' expectations of $748.79 million. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The firm's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the company posted $0.82 EPS. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, analysts forecast that Docusign Inc. will post 1.17 earnings per share for the current year.

Docusign declared that its Board of Directors has approved a stock buyback plan on Thursday, June 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to reacquire up to 6.6% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's leadership believes its stock is undervalued.

Insider Transactions at Docusign

In other Docusign news, CFO Blake Jeffrey Grayson sold 15,143 shares of Docusign stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $74.80, for a total value of $1,132,696.40. Following the completion of the transaction, the chief financial officer directly owned 110,723 shares of the company's stock, valued at $8,282,080.40. The trade was a 12.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $74.37, for a total transaction of $39,713.58. Following the sale, the director directly owned 8,805 shares in the company, valued at $654,827.85. This represents a 5.72% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 78,552 shares of company stock worth $5,983,631 over the last quarter. 1.01% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have recently issued reports on DOCU. JPMorgan Chase & Co. dropped their price objective on shares of Docusign from $81.00 to $77.00 and set a "neutral" rating on the stock in a research note on Friday, June 6th. Needham & Company LLC restated a "hold" rating on shares of Docusign in a report on Friday, June 6th. Morgan Stanley dropped their target price on Docusign from $92.00 to $86.00 and set an "equal weight" rating on the stock in a research report on Friday, June 6th. JMP Securities restated a "market outperform" rating and set a $124.00 price objective on shares of Docusign in a research note on Tuesday, June 3rd. Finally, Wedbush dropped their price objective on shares of Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a report on Thursday, June 12th. Four equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $89.77.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.